1.21
price down icon4.72%   -0.06
 
loading
iBio Inc stock is traded at $1.21, with a volume of 4.19M. It is down -4.72% in the last 24 hours and up +46.35% over the past month. iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$1.27
Open:
$1.26
24h Volume:
4.19M
Relative Volume:
1.59
Market Cap:
$23.78M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1825
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+42.35%
1M Performance:
+46.35%
6M Performance:
+42.86%
1Y Performance:
-56.79%
1-Day Range:
Value
$1.14
$1.27
1-Week Range:
Value
$0.8642
$1.72
52-Week Range:
Value
$0.5562
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Name
iBio Inc
Name
Phone
302-355-0650
Name
Address
600 Madison Avenue, Suite 1601, New York, NY
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
IBIO's Discussions on Twitter

Compare IBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IBIO
iBio Inc
1.21 25.72M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

iBio Inc Stock (IBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-21-25 Initiated Oppenheimer Outperform
Oct-17-25 Initiated Leerink Partners Outperform
May-28-24 Initiated Chardan Capital Markets Buy
Nov-29-21 Initiated JMP Securities Mkt Outperform
Jan-22-21 Initiated Cantor Fitzgerald Overweight
Jun-26-20 Initiated Alliance Global Partners Buy
View All

iBio Inc Stock (IBIO) Latest News

pulisher
Oct 24, 2025

Why iBio Inc. (0JV0) stock could be next leaderJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Risk vs reward if holding onto iBio Inc.2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Why iBio Inc. stock is rated strong buyMarket Movers & Weekly Consistent Profit Watchlists - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Analyzing iBio Inc. with multi timeframe chartsMarket Sentiment Report & Technical Pattern Alert System - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

How buybacks impact iBio Inc. stock valueJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Real time pattern detection on iBio Inc. stock2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

iBio (IBIO) Gains Attention with Promising Obesity Treatment - GuruFocus

Oct 24, 2025
pulisher
Oct 24, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Oct 24, 2025
pulisher
Oct 24, 2025

Does iBio Inc. (0JV0) stock trade below intrinsic value2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com

Oct 24, 2025
pulisher
Oct 23, 2025

iBio (IBIO) Gains Positive Outlook with Analyst Coverage and Inn - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

Is IBIO Stock On The Verge Of A Breakthrough? - StocksToTrade

Oct 23, 2025
pulisher
Oct 23, 2025

iBio Surges: Big Moves on the Horizon? - timothysykes.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is iBio Inc. stock attractive for long term wealth building2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times

Oct 23, 2025
pulisher
Oct 23, 2025

iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim - Stock Titan

Oct 23, 2025
pulisher
Oct 23, 2025

Why Did iBio Shares Surge Over 11% In Pre-Market Trading? - Benzinga

Oct 23, 2025
pulisher
Oct 22, 2025

IBIO insider Form 4: CFO awarded 75,000 options, vesting over 3 years - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

Form 4: iBio awards 55,000 options to Chief Legal Officer - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

What analysts say about iBio Inc 0JV0 stockGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in

Oct 22, 2025
pulisher
Oct 22, 2025

iBio (IBIO) Gains Attention with Innovative Drug Development - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Ibio Inc. sell Wolf_of_WS - sharewise.com

Oct 22, 2025
pulisher
Oct 22, 2025

iBio initiated with an Outperform at Oppenheimer - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Key resistance and support levels for iBio Inc.July 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

iBio Inc. stock retracement – recovery analysisMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

IBIO Stocks Skyrocket: An In-Depth Overview​ - StocksToTrade

Oct 21, 2025
pulisher
Oct 21, 2025

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Oppenheimer Initiates Coverage of iBio (IBIO) with Outperform Recommendation - Nasdaq

Oct 21, 2025
pulisher
Oct 21, 2025

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs - ts2.tech

Oct 21, 2025
pulisher
Oct 21, 2025

Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

Oppenheimer Initiates Coverage on IBIO with an Outperform Rating - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Is iBio Inc. (0JV0) stock worth holding before Fed meetingGap Down & Weekly Watchlist for Hot Stocks - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Oppenheimer initiates iBio stock with Outperform rating on obesity drug potential - Investing.com Canada

Oct 21, 2025
pulisher
Oct 20, 2025

What analysts say about iBio Inc stockMarket Insider Reports & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Oct 20, 2025
pulisher
Oct 20, 2025

How to manage a losing position in iBio Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Tick level data insight on iBio Inc. volatility2025 Institutional Moves & Detailed Earnings Play Strategies - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Form 4: iBio awards CEO 180,000 options; first vest 10/20/2026 - Stock Titan

Oct 20, 2025
pulisher
Oct 19, 2025

Real time alert setup for iBio Inc. performanceWeekly Trend Summary & Risk Managed Investment Strategies - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

iBio initiated with an Outperform at Leerink - MSN

Oct 19, 2025

iBio Inc Stock (IBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):